Part,  Chapter, Paragraph

1   II,     5.  6.  3|     citrullinated peptide antibodies marker (Combe et al, 2007).~ ~Natural
2   II,     5.  6.  3|               This appears to be the marker for RA disease severity
3   II,     5.  7.  7|        kidney, a cardiovascular risk marker, and a new target for therapy.
4   II,     9.  2.  3|           can be seen as an ultimate marker of adverse mental health,
5   II,     9.  3.  1|            is now seen as a sentinel marker for early stages of cardio-vascular
6   II,     9.  3.  2|      mortality is considered a major marker of health system performance
7  III,    10.  2.  2|            45 mg/dl) is considered a marker of increased risk that should
8  III,    10.  2.  4| insertion-deletion polymorphism as a marker of Alzheimer’s disease.